Skip to main content
×
Home
    • Aa
    • Aa

Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes

  • Laura Marroquí (a1) (a2), Paloma Alonso-Magdalena (a1) (a3), Beatriz Merino (a1) (a3), Esther Fuentes (a1) (a3), Angel Nadal (a1) (a3) and Ivan Quesada (a1) (a3)...
Abstract

Glucose homeostasis is precisely regulated by glucagon and insulin, which are released by pancreatic α- and β-cells, respectively. While β-cells have been the focus of intense research, less is known about α-cell function and the actions of glucagon. In recent years, the study of this endocrine cell type has experienced a renewed drive. The present review contains a summary of established concepts as well as new information about the regulation of α-cells by glucose, amino acids, fatty acids and other nutrients, focusing especially on glucagon release, glucagon synthesis and α-cell survival. We have also discussed the role of glucagon in glucose homeostasis and in energy and lipid metabolism as well as its potential as a modulator of food intake and body weight. In addition to the well-established action on the liver, we discuss the effects of glucagon in other organs, where the glucagon receptor is expressed. These tissues include the heart, kidneys, adipose tissue, brain, small intestine and the gustatory epithelium. Alterations in α-cell function and abnormal glucagon concentrations are present in diabetes and are thought to aggravate the hyperglycaemic state of diabetic patients. In this respect, several experimental approaches in diabetic models have shown important beneficial results in improving hyperglycaemia after the modulation of glucagon secretion or action. Moreover, glucagon receptor agonism has also been used as a therapeutic strategy to treat obesity.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes
      Available formats
      ×
Copyright
Corresponding author
* Corresponding author: Dr I. Quesada, +34 96 522 2033, email ivanq@umh.es
References
Hide All
1 BrissovaM, FowlerMJ, NicholsonWE, et al. (2005) Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 53, 10871097.
2 CabreraO, BermanDM, KenyonNS, et al. (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103, 23342339.
3 NadalA, QuesadaI & SoriaB (1999) Homologous and heterologous asynchronicity between identified α-, β- and δ-cells within intact islets of Langerhans in the mouse. J Physiol 517, 8593.
4 QuesadaI, TodorovaMG & SoriaB (2006) Different metabolic responses in α-, β-, and δ-cells of the islet of Langerhans monitored by redox confocal microscopy. Biophys J 90, 26412650.
5 SmithFE, RosenKM, Villa-KomaroffL, et al. (1991) Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci U S A 88, 61526156.
6 UngerRH & OrciL (2010) Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci U S A 107, 1600916012.
7 AhrenB (2000) Autonomic regulation of islet hormone secretion – implications for health and disease. Diabetologia 43, 393410.
8 TaborskyGJJr & MundingerTO (2012) Minireview: the role of the autonomic nervous system in mediating the glucagon response to hypoglycemia. Endocrinology 153, 10551062.
9 QuesadaI, TuduriE, RipollC, et al. (2008) Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol 199, 519.
10 UngerRH, Aguilar-ParadaE, MullerWA, et al. (1970) Studies of pancreatic α cell function in normal and diabetic subjects. J Clin Invest 49, 837848.
11 ArafatAM, KaczmarekP, SkrzypskiM, et al. (2013) Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? Diabetologia 56, 588597.
12 BertinE, ArnerP, BolinderJ, et al. (2001) Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo . J Clin Endocrinol Metab 86, 12291234.
13 LonguetC, SinclairEM, MaidaA, et al. (2008) The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab 8, 359371.
14 XiaoC, PavlicM, SzetoL, et al. (2011) Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans. Diabetes 60, 383390.
15 CryerPE (2012) Minireview: glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes. Endocrinology 153, 10391048.
16 GerichJE, LorenziM, SchneiderV, et al. (1974) Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man. J Clin Endocrinol Metab 39, 10571060.
17 OhnedaA, Aguilar-ParadaE, EisentrautAM, et al. (1969) Control of pancreatic glucagon secretion by glucose. Diabetes 18, 110.
18 SalehiA & VieiraE (2006) Gylfe E Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes 55, 23182323.
19 VieiraE & SalehiA (2007) Gylfe E Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic α cells. Diabetologia 50, 370379.
20 GopelS, ZhangQ, EliassonL, et al. (2004) Capacitance measurements of exocytosis in mouse pancreatic α-, β- and δ-cells within intact islets of Langerhans. J Physiol 556, 711726.
21 GopelSO, KannoT, BargS, et al. (2000) Regulation of glucagon release in mouse α-cells by KATP channels and inactivation of TTX-sensitive Na+ channels. J Physiol 528, 509520.
22 TuduriE, MarroquiL, SorianoS, et al. (2009) Inhibitory effects of leptin on pancreatic α-cell function. Diabetes 58, 16161624.
23 TaborskyGJJr, AhrenB & HavelPJ (1998) Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired α-cell responses in type 1 diabetes. Diabetes 47, 9951005.
24 ThorensB (2011) Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab 13, Suppl. 1, 8288.
25 RorsmanP, SalehiSA, AbdulkaderF, et al. (2008) K(ATP)-channels and glucose-regulated glucagon secretion. Trends Endocrinol Metab 19, 277284.
26 MacDonaldPE, De MarinisYZ, RamracheyaR, et al. (2007) A KATP channel-dependent pathway within α cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol 5, e143.
27 GylfeE (2013) Glucose control of glucagon secretion: there is more to it than KATP channels. Diabetes 62, 13911393.
28 LiuYJ, VieiraE & GylfeE (2004) A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting pancreatic α-cell. Cell Calcium 35, 357365.
29 QuoixN, Cheng-XueR & MattartL (2009) Glucose and pharmacological modulators of ATP-sensitive K+ channels control [Ca2+]c by different mechanisms in isolated mouse α-cells. Diabetes 58, 412421.
30 Le MarchandSJ & PistonDW (2010) Glucose suppression of glucagon secretion: metabolic and calcium responses from α-cells in intact mouse pancreatic islets. J Biol Chem 285, 1438914398.
31 RavierMA & RutterGA (2005) Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic α-cells. Diabetes 54, 17891797.
32 DetimaryP, DejongheS, LingZ, et al. (1998) The changes in adenine nucleotides measured in glucose-stimulated rodent islets occur in β cells but not in α cells and are also observed in human islets. J Biol Chem 273, 3390533908.
33 GorusFK, MalaisseWJ & PipeleersDG (1984) Differences in glucose handling by pancreatic A- and B-cells. J Biol Chem 259, 11961200.
34 HeimbergH, De VosA, PipeleersD, et al. (1995) Differences in glucose transporter gene expression between rat pancreatic α- and β-cells are correlated to differences in glucose transport but not in glucose utilization. J Biol Chem 270, 89718975.
35 SchuitF, De VosA, FarfariS, et al. (1997) Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in β cells. J Biol Chem 272, 1857218579.
36 SekineS, ItoY, HashimotoM, et al. (1994) Characterization of monoclonal antibodies to chitinase A1 and enhancement of chitinase A1 activity by monoclonal antibodies. Biochem Biophys Res Commun 204, 716.
37 ZhaoC, WilsonMC, SchuitF, et al. (2001) Expression and distribution of lactate/monocarboxylate transporter isoforms in pancreatic islets and the exocrine pancreas. Diabetes 50, 361366.
38 AllisterEM, Robson-DoucetteCA, PrenticeKJ, et al. (2013) UCP2 regulates the glucagon response to fasting and starvation. Diabetes 62, 16231633.
39 Cheng-XueR, Gomez-RuizA, AntoineN, et al. (2013) Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both α-cells and δ-cells. Diabetes 62, 16121622.
40 da Silva XavierG, FarhanH, KimH, et al. (2011) Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion. Diabetologia 54, 819827.
41 LeclercI, SunG, MorrisC, et al. (2011) AMP-activated protein kinase regulates glucagon secretion from mouse pancreatic α cells. Diabetologia 54, 125134.
42 VieiraE, MarroquíL, FigueroaAC, et al. (2013) Involvement of the clock gene Rev-erb α in the regulation of glucagon secretion in pancreatic α-cells. PLOS ONE 8, e69939.
43 EllingsgaardH, EhsesJA, HammarEB, et al. (2008) Interleukin-6 regulates pancreatic α-cell mass expansion. Proc Natl Acad Sci U S A 105, 1316313168.
44 DumonteilE, MagnanC, Ritz-LaserB, et al. (2000) Glucose regulates proinsulin and prosomatostatin but not proglucagon messenger ribonucleic acid levels in rat pancreatic islets. Endocrinology 141, 174180.
45 KuharaT, IkedaS, OhnedaA, et al. (1991) Effects of intravenous infusion of 17 amino acids on the secretion of GH, glucagon, and insulin in sheep. Am J Physiol 260, E21E26.
46 PipeleersDG, SchuitFC, Van SchravendijkCF, et al. (1985) Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117, 817823.
47 OstensonCG (1985) Grebing C Evidence for metabolic regulation of pancreatic glucagon secretion by l-glutamine. Acta Endocrinol (Copenh) 108, 386391.
48 LiXC, LiaoTD & ZhuoJL (2008) Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of type 2 diabetes in mice. Clin Sci (Lond) 114, 591601.
49 GannonMC, NuttallJA & NuttallFQ (2002) The metabolic response to ingested glycine. Am J Clin Nutr 76, 13021307.
50 Leclercq-MeyerV, MarchandJ, Woussen-ColleMC, et al. (1985) Multiple effects of leucine on glucagon, insulin, and somatostatin secretion from the perfused rat pancreas. Endocrinology 116, 11681174.
51 BodeHP, WeberS, FehmannHC, et al. (1999) A nutrient-regulated cytosolic calcium oscillator in endocrine pancreatic glucagon-secreting cells. Pflugers Arch 437, 324334.
52 CollinsSC, LuanJ, ThompsonAJ, et al. (2007) Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations. Diabetologia 50, 555562.
53 HongJ, AbudulaR, ChenJ, et al. (2005) The short-term effect of fatty acids on glucagon secretion is influenced by their chain length, spatial configuration, and degree of unsaturation: studies in vitro . Metabolism 54, 13291336.
54 OlofssonCS, SalehiA, GopelSO, et al. (2004) Palmitate stimulation of glucagon secretion in mouse pancreatic α-cells results from activation of l-type calcium channels and elevation of cytoplasmic calcium. Diabetes 53, 28362843.
55 BollheimerLC, LandauerHC, TrollS, et al. (2004) Stimulatory short-term effects of free fatty acids on glucagon secretion at low to normal glucose concentrations. Metabolism 53, 14431448.
56 FlodgrenE, OldeB, Meidute-AbaravicieneS, et al. (2007) GPR40 is expressed in glucagon producing cells and affects glucagon secretion. Biochem Biophys Res Commun 354, 240245.
57 WangL, ZhaoY, GuiB, et al. (2011) Acute stimulation of glucagon secretion by linoleic acid results from GPR40 activation and [Ca2+]i increase in pancreatic islet α-cells. J Endocrinol 210, 173179.
58 FujiwaraK, MaekawaF, DezakiK, et al. (2007) Oleic acid glucose-independently stimulates glucagon secretion by increasing cytoplasmic Ca2+ via endoplasmic reticulum Ca2+ release and Ca2+ influx in the rat islet α-cells. Endocrinology 148, 24962504.
59 HongJ, JeppesenPB, NordentoftI, et al. (2007) Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation. Diabetes Metab Res Rev 23, 202210.
60 PiroS, ManiscalchiET, MonelloA, et al. (2010) Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic α-cell line. Endocrinology 151, 41974206.
61 GremlichS, BonnyC, WaeberG, et al. (1997) Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J Biol Chem 272, 3026130269.
62 BourlonPM, Faure-DussertA, BillaudelB, et al. (1996) Relationship between calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 deficiency and 1,25-dihydroxyvitamin D3 . J Endocrinol 148, 223232.
63 OrwollE & RiddleM (1994) Prince M Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59, 10831087.
64 ChertowBS, DriscollHK, BlanerWS, et al. (1994) Effects of vitamin A deficiency and repletion on rat glucagon secretion. Pancreas 9, 475484.
65 ChertowBS, DriscollHK, PrimeranoDA, et al. (1996) Retinoic acid receptor transcripts and effects of retinol and retinoic acid on glucagon secretion from rat islets and glucagon-secreting cell lines. Metabolism 45, 300305.
66 KlandorfH & ClarkeBL (1987) Brown J Altered glucagon release in biotin deficiency. Gen Comp Endocrinol 65, 133140.
67 WilkesLC, BaileyCJ, ThompsonB, et al. (1990) Effect of gastrin-releasing peptide on the secretion of mouse islet hormones in vitro . J Endocrinol 127, 335340.
68 WinzellMS (2007) Ahren B Role of VIP and PACAP in islet function. Peptides 28, 18051813.
69 MirallesP, PeiroE, DeganoP, et al. (1990) Inhibition of insulin and somatostatin secretion and stimulation of glucagon release by homologous galanin in perfused rat pancreas. Diabetes 39, 9961001.
70 De MarinisYZ, SalehiA, WardCE, et al. (2010) GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab 11, 543553.
71 CabreraO, Jacques-SilvaMC, SpeierS, et al. (2008) Glutamate is a positive autocrine signal for glucagon release. Cell Metab 7, 545554.
72 Rodriguez-DiazR, DandoR, Jacques-SilvaMC, et al. (2011) α Cells secrete acetylcholine as a non-neuronal paracrine signal priming β cell function in humans. Nat Med 17, 888892.
73 MikiT, LissB, MinamiK, et al. (2001) ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 4, 507512.
74 LeibigerB, MoedeT, MuhandiramlageTP, et al. (2012) Glucagon regulates its own synthesis by autocrine signaling. Proc Natl Acad Sci U S A 109, 2092520930.
75 TuduriE, FiliputtiE, CarneiroEM, et al. (2008) Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic α-cells by extracellular ATP and purinergic receptors. Am J Physiol Endocrinol Metab 294, E952E960.
76 MaX, ZhangY, GromadaJ, et al. (2005) Glucagon stimulates exocytosis in mouse and rat pancreatic α-cells by binding to glucagon receptors. Mol Endocrinol 19, 198212.
77 DunningBE & FoleyJE (2005) Ahren B α Cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48, 17001713.
78 DingWG, RenstromE, RorsmanP, et al. (1997) Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat α-cells by a protein kinase A-mediated mechanism. Diabetes 46, 792800.
79 de HeerJ, RasmussenC, CoyDH, et al. (2008) Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 51, 22632270.
80 OparaEC, BurchWM, TaylorIL, et al. (1991) Pancreatic hormone response to neuropeptide Y (NPY) perifusion in vitro . Regul Pept 34, 225233.
81 GosmainY, CheyssacC, et al. (2011) Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α-cell differentiation, glucagon biosynthesis and secretion. Diabetes Obes Metab 13, Suppl. 1, 3138.
82 JinT (2008) Mechanisms underlying proglucagon gene expression. J Endocrinol 198, 1728.
83 MojsovS, HeinrichG, WilsonIB, et al. (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 261, 1188011889.
84 DeyA, LipkindGM, RouilleY, et al. (2005) Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon. Endocrinology 146, 713727.
85 PatzeltC & SchiltzE (1984) Conversion of proglucagon in pancreatic α cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences. Proc Natl Acad Sci U S A 81, 50075011.
86 PatzeltC, TagerHS, CarrollRJ, et al. (1979) Identification and processing of proglucagon in pancreatic islets. Nature 282, 260266.
87 FurutaM, ZhouA, WebbG, et al. (2001) Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J Biol Chem 276, 2719727202.
88 DumonteilE, Ritz-LaserB, MagnanC, et al. (1999) Chronic exposure to high glucose concentrations increases proglucagon messenger ribonucleic acid levels and glucagon release from InR1G9 cells. Endocrinology 140, 46444650.
89 McGirrR, EjbickCE, CarterDE, et al. (2005) Glucose dependence of the regulated secretory pathway in αTC1-6 cells. Endocrinology 146, 45144523.
90 GrzeskowiakR, AminJ, OetjenE, et al. (2000) Insulin responsiveness of the glucagon gene conferred by interactions between proximal promoter and more distal enhancer-like elements involving the paired-domain transcription factor Pax6. J Biol Chem 275, 3003730045.
91 PhilippeJ (1989) Glucagon gene transcription is negatively regulated by insulin in a hamster islet cell line. J Clin Invest 84, 672677.
92 SchinnerS, BarthelA, DellasC, et al. (2005) Protein kinase B activity is sufficient to mimic the effect of insulin on glucagon gene transcription. J Biol Chem 280, 73697376.
93 YamatoE, NomaY, TaharaY, et al. (1990) Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7-36 amide) without affect on mRNA level in isolated rat islets. Biochem Biophys Res Commun 167, 431437.
94 PaulGL, WaegnerA, GaskinsHR, et al. (1998) Histidine availability alters glucagon gene expression in murine αTC6 cells. J Nutr 128, 973976.
95 MayoKE, MillerLJ, BatailleD, et al. (2003) International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55, 167194.
96 WeinsteinLS, YuS, WarnerDR, et al. (2001) Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting. Endocr Rev 22, 675705.
97 KimballSR, SiegfriedBA & JeffersonLS (2004) Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J Biol Chem 279, 5410354109.
98 ChenJ, IshacEJ, DentP, et al. (1998) Effects of ethanol on mitogen-activated protein kinase and stress-activated protein kinase cascades in normal and regenerating liver. Biochem J 334, 669676.
99 SvobodaM, TastenoyM, VertongenP, et al. (1994) Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Mol Cell Endocrinol 105, 131137.
100 KedeesMH, GrigoryanM, GuzY, et al. (2009) Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic α and β cells in two models of α cell hyperplasia. Mol Cell Endocrinol 311, 6976.
101 KiefferTJ, HellerRS, UnsonCG, et al. (1996) Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets. Endocrinology 137, 51195125.
102 GellingRW, DuXQ, DichmannDS, et al. (2003) Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A 100, 14381443.
103 ConarelloSL, JiangG, MuJ, et al. (2007) Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated β cell loss and hyperglycaemia. Diabetologia 50, 142150.
104 LeeY, WangMY, DuXQ, et al. (2011) Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 60, 391397.
105 SorensenH, WinzellMS, BrandCL, et al. (2006) Glucagon receptor knockout mice display increased insulin sensitivity and impaired β-cell function. Diabetes 55, 34633469.
106 VuguinPM, KedeesMH, CuiL, et al. (2006) Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 147, 39954006.
107 GellingRW, VuguinPM, DuXQ, et al. (2009) Pancreatic β-cell overexpression of the glucagon receptor gene results in enhanced β-cell function and mass. Am J Physiol Endocrinol Metab 297, E695E707.
108 BerglundED, LustigDG, BahezaRA, et al. (2011) Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver. Diabetes 60, 27202729.
109 JonesBJ, TanT & BloomSR (2012) Minireview: glucagon in stress and energy homeostasis. Endocrinology 153, 10491054.
110 YoonJC, PuigserverP, ChenG, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131138.
111 HjorthSA, AdelhorstK, PedersenBB, et al. (1994) Glucagon and glucagon-like peptide 1: selective receptor recognition via distinct peptide epitopes. J Biol Chem 269, 3012130124.
112 HerzigS, LongF, JhalaUS, et al. (2001) CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179183.
113 BandGC & JonesCT (1980) Functional activation by glucagon of glucose 6-phosphatase and gluconeogenesis in the perfused liver of the fetal guinea pig. FEBS Lett 119, 190194.
114 De OyaM, PriggeWF & GrandeF (1971) Suppression by hepatectomy of glucagon-induced hypertriglyceridemia in geese. Proc Soc Exp Biol Med 136, 107110.
115 PenhosJC, WuCH, DaunasJ, et al. (1966) Effect of glucagon on the metabolism of lipids and on urea formation by the perfused rat liver. Diabetes 15, 740748.
116 AubryF, MarcelYL & DavignonJ (1974) Effects of glucagon on plasma lipids in different types of primary hyperlipoproteinemia. Metabolism 23, 225238.
117 EatonRP (1973) Hypolipemic action of glucagon in experimental endogenous lipemia in the rat. J Lipid Res 14, 312318.
118 CharbonneauA, CouturierK, GauthierMS, et al. (2005) Evidence of hepatic glucagon resistance associated with hepatic steatosis: reversal effect of training. Int J Sports Med 26, 432441.
119 CharbonneauA, MelanconA, LavoieC, et al. (2005) Alterations in hepatic glucagon receptor density and in Gsα and Giα2 protein content with diet-induced hepatic steatosis: effects of acute exercise. Am J Physiol Endocrinol Metab 289, E8E14.
120 HanS, AkiyamaTE, PrevisSF, et al. (2013) Effects of siRNA-mediated hepatic glucagon receptor inhibition on lipid metabolism in db/db mice. J Lipid Res 54, 26152622.
121 CynoberLA (2002) Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18, 761766.
122 HooseinNM & GurdRS (1984) Identification of glucagon receptors in rat brain. Proc Natl Acad Sci U S A 81, 43684372.
123 CockramCS, KumW, HoSK, et al. (1995) Binding and action of glucagon in cultured mouse astrocytes. Glia 13, 141146.
124 InokuchiA, OomuraY & NishimuraH (1984) Effect of intracerebroventricularly infused glucagon on feeding behavior. Physiol Behav 33, 397400.
125 AmirS (1986) Central glucagon-induced hyperglycemia is mediated by combined activation of the adrenal medulla and sympathetic nerve endings. Physiol Behav 37, 563566.
126 GearyN & SmithGP (1983) Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiol Behav 31, 391394.
127 GearyN & SmithGP (1982) Pancreatic glucagon and postprandial satiety in the rat. Physiol Behav 28, 313322.
128 MartinJR & NovinD (1977) Decreased feeding in rats following hepatic-portal infusion of glucagon. Physiol Behav 19, 461466.
129 PenickSB & HinkleLEJr (1961) Depression of food intake induced in healthy subjects by glucagon. N Engl J Med 264, 893897.
130 WoodsSC, LutzTA, GearyN, et al. (2006) Pancreatic signals controlling food intake; insulin, glucagon and amylin. Philos Trans R Soc Lond B Biol Sci 361, 12191235.
131 LanghansW, ZeigerU, ScharrerE, et al. (1982) Stimulation of feeding in rats by intraperitoneal injection of antibodies to glucagon. Science 218, 894896.
132 JensenPB, BlumeN, MikkelsenJD, et al. (1998) Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. J Clin Invest 101, 503510.
133 ArafatAM, PerschelFH, OttoB, et al. (2006) Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level. J Clin Endocrinol Metab 91, 35283533.
134 MighiuPI, YueJT, FilippiBM, et al. (2013) Hypothalamic glucagon signaling inhibits hepatic glucose production. Nat Med 19, 766772.
135 DavidsonIW, SalterJM & BestCH (1957) Calorigenic action of glucagon. Nature 180, 1124.
136 NairKS (1987) Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency. J Clin Endocrinol Metab 64, 896901.
137 Calles-EscandonJ (1994) Insulin dissociates hepatic glucose cycling and glucagon-induced thermogenesis in man. Metabolism 43, 10001005.
138 TanTM, FieldBC, McCulloughKA, et al. (2013) Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. Diabetes 62, 11311138.
139 BillingtonCJ, BriggsJE, LinkJG, et al. (1991) Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo . Am J Physiol 261, R501R507.
140 JoelCD (1966) Stimulation of metabolism of rat brown adipose tissue by addition of lipolytic hormones in vitro . J Biol Chem 241, 814821.
141 YahataT & KuroshimaA (1982) Influence of endocrine and chemical factors on glucagon induced thermogenesis in brown adipocytes. Jpn J Physiol 32, 303307.
142 BillingtonCJ, BartnessTJ, BriggsJ, et al. (1987) Glucagon stimulation of brown adipose tissue growth and thermogenesis. Am J Physiol 252, R160R165.
143 Filali-ZegzoutiY, AbdelmelekH, RouanetJL, et al. (2005) Role of catecholamines in glucagon-induced thermogenesis. J Neural Transm 112, 481489.
144 DickerA, ZhaoJ, CannonB, et al. (1998) Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells. Am J Physiol 275, R1674R1682.
145 SchulmanJL, CarletonJL, WhitneyG, et al. (1957) Effect of glucagon on food intake and body weight in man. J Appl Physiol 11, 419421.
146 ChanEK, MackeyMA, SnoverDC, et al. (1984) Suppression of weight gain by glucagon in obese Zucker rats. Exp Mol Pathol 40, 320327.
147 HabeggerKM, StemmerK, ChengC, et al. (2013) Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes 62, 14531463.
148 LiuZ, KimW, ChenZ, et al. (2011) Insulin and glucagon regulate pancreatic α-cell proliferation. PLoS ONE 6, e16096.
149 MoensK, HeimbergH, FlamezD, et al. (1996) Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45, 257261.
150 MeryPF, BrechlerV, PavoineC, et al. (1990) Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase. Nature 345, 158161.
151 Gonzalez-MunozC, Nieto-CeronS, Cabezas-HerreraJ, et al. (2008) Glucagon increases contractility in ventricle but not in atrium of the rat heart. Eur J Pharmacol 587, 243247.
152 HarneyJA & RodgersRL (2008) Insulin-like stimulation of cardiac fuel metabolism by physiological levels of glucagon: involvement of PI3K but not cAMP. Am J Physiol Endocrinol Metab 295, E155E161.
153 HeckemeyerCM, BarkerJ, DuckworthWC, et al. (1983) Studies of the biological effect and degradation of glucagon in the rat perifused isolated adipose cell. Endocrinology 113, 270276.
154 PereaA, ClementeF, MartinellJ, et al. (1995) Physiological effect of glucagon in human isolated adipocytes. Horm Metab Res 27, 372375.
155 GravholtCH, MollerN, JensenMD, et al. (2001) Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis. J Clin Endocrinol Metab 86, 20852089.
156 LefebvreP, LuyckxA & BacqZM (1973) Effects of denervation on the metabolism and the response to glucagon of white adipose tissue of rats. Horm Metab Res 5, 245250.
157 AhloulayM, BoubyN, MachetF, et al. (1992) Effects of glucagon on glomerular filtration rate and urea and water excretion. Am J Physiol 263, F24F36.
158 YanoY, CesarKR, AraujoM, et al. (2009) Aquaporin 2 expression increased by glucagon in normal rat inner medullary collecting ducts. Am J Physiol Renal Physiol 296, F54F59.
159 GutzeitA, BinkertCA, KohDM, et al. (2012) Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administration. Eur Radiol 22, 11861194.
160 MochikiE, SuzukiH, TakenoshitaS, et al. (1998) Mechanism of inhibitory effect of glucagon on gastrointestinal motility and cause of side effects of glucagon. J Gastroenterol 33, 835841.
161 AmandaB, ManuelaM, AntoniaM, et al. (2010) Posturography measures and efficacy of different physical treatments in somatic tinnitus. Int Tinnitus J 16, 4450.
162 LarssonH (2000) Ahren B Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 23, 650657.
163 ReavenGM, ChenYD, GolayA, et al. (1987) Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64, 106110.
164 SherwinR, WahrenJ & FeligP (1976) Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis. Metabolism 25, 13811383.
165 GastaldelliA, BaldiS, PettitiM, et al. (2000) Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49, 13671373.
166 SiafarikasA, JohnstonRJ, BulsaraMK, et al. (2012) Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care 35, 17571762.
167 DinneenS, AlzaidA, TurkD, et al. (1995) Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia 38, 337343.
168 ShahP, VellaA, BasuA, et al. (2000) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85, 40534059.
169 EldorR, GlaserB, FraenkelM, et al. (2011) Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour. Clin Endocrinol (Oxf) 74, 593598.
170 BolliG, De FeoP, PerrielloG, et al. (1984) Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the β cell and arterial hyperinsulinemia. J Clin Invest 73, 917922.
171 ZhouH, ZhangT, HarmonJS, et al. (2007) Zinc, not insulin, regulates the rat α-cell response to hypoglycemia in vivo . Diabetes 56, 11071112.
172 ZhouH, ZhangT, OseidE, et al. (2007) Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats. Endocrinology 148, 28632869.
173 DengS, VatamaniukM, HuangX, et al. (2004) Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes 53, 624632.
174 HenquinJC & RahierJ (2011) Pancreatic α cell mass in European subjects with type 2 diabetes. Diabetologia 54, 17201725.
175 YoonKH, KoSH, ChoJH, et al. (2003) Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 88, 23002308.
176 CharltonMR, AdeyDB & NairKS (1996) Evidence for a catabolic role of glucagon during an amino acid load. J Clin Invest 98, 9099.
177 TessariP, InchiostroS, BarazzoniR, et al. (1996) Hyperglucagonemia stimulates phenylalanine oxidation in humans. Diabetes 45, 463470.
178 RothE, MuhlbacherF, KarnerJ, et al. (1987) Free amino acid levels in muscle and liver of a patient with glucagonoma syndrome. Metabolism 36, 713.
179 CharltonMR & NairKS (1998) Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate. Diabetes 47, 17481756.
180 BodenG, RezvaniI & OwenOE (1984) Effects of glucagon on plasma amino acids. J Clin Invest 73, 785793.
181 SlavinBG, OngJM & KernPA (1994) Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res 35, 15351541.
182 GuettetC, RostaquiN, MatheD, et al. (1991) Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats. Lipids 26, 451458.
183 GuettetC, RostaquiN, NavarroN, et al. (1991) Effect of chronic glucagon administration on the metabolism of triacylglycerol-rich lipoproteins in rats fed a high sucrose diet. J Nutr 121, 2430.
184 BeylotM, PicardS, ChambrierC, et al. (1991) Effect of physiological concentrations of insulin and glucagon on the relationship between nonesterified fatty acids availability and ketone body production in humans. Metabolism 40, 11381146.
185 MilesJM, HaymondMW, NissenSL, et al. (1983) Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man. J Clin Invest 71, 15541561.
186 OkudaY, KawaiK & YamashitaK (1987) Age-related change in ketone body metabolism: diminished glucagon effect on ketogenesis in adult rats. Endocrinology 120, 21522157.
187 TaborskyGJJr (2010) The physiology of glucagon. J Diabetes Sci Technol 4, 13381344.
188 WahidM, NaveedAK & HussainI (2006) Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes. J Coll Physicians Surg Pak 16, 1114.
189 HancockAS, DuA, LiuJ, et al. (2010) Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. Mol Endocrinol 24, 16051614.
190 LeeY, BerglundED, WangMY, et al. (2012) Metabolic manifestations of insulin deficiency do not occur without glucagon action. Proc Natl Acad Sci U S A 109, 1497214976.
191 SinclairEM, YustaB, StreutkerC, et al. (2008) Glucagon receptor signaling is essential for control of murine hepatocyte survival. Gastroenterology 135, 20962106.
192 ParkerJC, McPhersonRK, AndrewsKM, et al. (2000) Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes. Diabetes 49, 20792086.
193 PetersenKF & SullivanJT (2001) Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia 44, 20182024.
194 SloopKW, CaoJX, SieskyAM, et al. (2004) Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J Clin Invest 113, 15711581.
195 WinzellMS, BrandCL, WierupN, et al. (2007) Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet. Diabetologia 50, 14531462.
196 MillerRA, ChuQ, XieJ, et al. (2013) Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 494, 256260.
197 DayJW, OttawayN, PattersonJT, et al. (2009) A new glucagon and GLP-1 co-agonist eliminates obesity in rodents. Nat Chem Biol 5, 749757.
198 PocaiA, CarringtonPE, AdamsJR, et al. (2009) Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice. Diabetes 58, 22582266.
199 ParkerJA, McCulloughKA, FieldBC, et al. (2013) Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int J Obes (Lond) 37, 13911398.
200 NauckMA, HeimesaatMM, BehleK, et al. (2002) Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 87, 12391246.
201 DupreJ, BehmeMT & McDonaldTJ (2004) Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes. J Clin Endocrinol Metab 89, 34693473.
202 EdgertonDS, JohnsonKM & CherringtonAD (2009) Current strategies for the inhibition of hepatic glucose production in type 2 diabetes. Front Biosci 14, 11691181.
203 BalasB, BaigMR, WatsonC, et al. (2007) The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients. J Clin Endocrinol Metab 92, 12491255.
204 LebovitzHE (2010) Adjunct therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 6, 326334.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Nutrition Research Reviews
  • ISSN: 0954-4224
  • EISSN: 1475-2700
  • URL: /core/journals/nutrition-research-reviews
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 17
Total number of PDF views: 136 *
Loading metrics...

Abstract views

Total abstract views: 554 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 23rd October 2017. This data will be updated every 24 hours.